Insider Selling: Addus HomeCare (NASDAQ:ADUS) EVP Sells $78,416.34 in Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Darby Anderson sold 733 shares of the business’s stock in a transaction that occurred on Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total transaction of $78,416.34. Following the transaction, the executive vice president directly owned 46,642 shares in the company, valued at $4,989,761.16. The trade was a 1.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Darby Anderson also recently made the following trade(s):

• On Wednesday, February 25th, Darby Anderson sold 396 shares of Addus HomeCare stock. The stock was sold at an average price of $105.36, for a total transaction of $41,722.56.

Addus HomeCare Trading Down 0.5%

Shares of NASDAQ:ADUS opened at $103.53 on Friday. The firm has a fifty day moving average of $109.22 and a two-hundred day moving average of $112.95. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $124.43. The firm has a market capitalization of $1.92 billion, a P/E ratio of 19.87, a price-to-earnings-growth ratio of 1.44 and a beta of 0.91.

Key Headlines Impacting Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
• Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
• Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
• Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
• Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
• Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

Wall Street Analyst Weigh In

ADUS has been the topic of a number of research reports. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a report on Wednesday. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. TD Cowen restated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. BMO Capital Markets initiated coverage on shares of Addus HomeCare in a report on Thursday, November 13th. They set a “market perform” rating and a $120.00 price target on the stock. Finally, Barclays reduced their price objective on shares of Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $134.33.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Capital Research Global Investors grew its position in shares of Addus HomeCare by 22.3% in the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after purchasing an additional 268,192 shares during the last quarter. Vanguard Group Inc. boosted its stake in Addus HomeCare by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock valued at $140,531,000 after purchasing an additional 10,501 shares during the period. Wasatch Advisors LP boosted its stake in Addus HomeCare by 0.8% during the 3rd quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock valued at $110,467,000 after purchasing an additional 7,089 shares during the period. State Street Corp grew its holdings in Addus HomeCare by 0.9% in the 4th quarter. State Street Corp now owns 702,229 shares of the company’s stock valued at $75,412,000 after buying an additional 6,561 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Addus HomeCare by 1.2% in the 3rd quarter. Dimensional Fund Advisors LP now owns 667,256 shares of the company’s stock valued at $78,729,000 after buying an additional 7,884 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.